EGFR and non-small cell lung carcinoma: Over-expression of EGFR appear in nearly 60% of NSCLC patients [7], who frequently harbor EGFR mutations (like L858R) that will lead to aberrant singling, enhanced cell proliferation and progression of lung cancer.